Quest Diagnostics Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Mizuho Securities Raises Price Target on Quest Diagnostics (DGX) Following In-Line 1Q Results
April 21, 2016 2:16 PM EDTMizuho Securities reiterated an Outperform rating on Quest Diagnostics (NYSE: DGX), and raised the price target to $84.00 (from $75.00), following the company's 1Q earnings report. DGX reported an adjusted EPS of $1.12, in-line with consensus estimates.
Analyst Ann Hynes commented, "We are raising our price... More
Quest Diagnostics (DGX) Reports In-Line Q1 EPS; Reaffirms Outlook
April 21, 2016 6:47 AM EDTQuest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.12, in-line with the analyst estimate of $1.12. Revenue for the quarter came in at $1.86 billion versus the consensus estimate of $1.82 billion.
"We're off to a good start in 2016 with a solid performance in the first... More
